Private Equity

Daiwa Corporate Investment Co., Ltd.

Investment Details

Investor Type
Private Equity

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Seed, Early Stage, Growth, Late Stage, Buyout

Geographical Focus
Japan, China, Vietnam, Taiwan

Industries Focus

  • Financial Services
  • Technology
  • Healthcare
  • Consumer Goods
  • Real Estate
  • Infrastructure
  • Telecommunications
  • Media
  • Automotive
  • Retail
  • Renewable Energy
  • Agriculture
  • Logistics
  • Manufacturing
  • Biotechnology

Investment Size:
1,000,000 to 50,000,000 USD

Investor Details Founded: 1982

Daiwa Corporate Investment Co., Ltd. is a Japanese private equity firm specializing in venture capital and buyout investments across various industries. Established in 1982, the firm has a history of contributing to the growth and stock listings of numerous companies. It focuses on creating and revitalizing industries to contribute to the sustainable development of a vibrant economy and society through its fund businesses. The firm defines its role as a bridge between the demands of entrepreneurs and investors, aiming to realize profit for all parties involved.

The firm's investment strategy encompasses a wide range of sectors, including technology, healthcare, consumer goods, biotechnology, renewable energy, infrastructure, telecommunications, media, retail, manufacturing, automotive, financial services, real estate, agriculture, and logistics. Daiwa Corporate Investment engages in investments at various stages, from seed and early-stage to growth, late-stage, and buyouts. Geographically, the firm focuses on Japan, China, Taiwan, and Vietnam, reflecting its commitment to fostering economic development in these regions.

With over 40 years of experience, Daiwa Corporate Investment has established itself as a reliable manager and administrator of funds. As of the end of March 2025, the firm has formed 92 funds, invested a total of 470 billion JPY, and supported 2,369 companies, achieving 672 IPOs. The firm's subsidiary, DCI Partners, specializes in biotech investments, further diversifying its portfolio and expertise in the private equity sector.

Requirements
  • Strong growth potential
  • Innovative business models
  • Experienced management teams
  • Scalable operations
  • Clear exit strategies
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Stockmark
  • Highreso Kagawa Co., Ltd.
Claim this Investor

Are you an official representative of Daiwa Corporate Investment Co., Ltd.?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim